OBJECTIVE: Though nasal continuous positive airway pressure (NCPAP) is commonly used for non-invasive neonatal respiratory support, the optimal method of weaning NCPAP is not established. In this prospective, two-center randomized control trial we hypothesize that gradually increasing spontaneous breathing time off NCPAP increases successful weaning from NCPAP in infants born o 31 weeks gestational age. STUDY DESIGN: Infants were randomized to one of the two NCPAP weaning protocols, a sprinting, that is, gradually increasing spontaneous breathing time off CPAP, protocol vs a non-sprinting (weaning pressure down) protocol. RESULT: Eighty-six infants were enrolled in one of the two study groups. Thirty-one infants (77%) in the sprinting group and 30 (75%) in the non-sprinting group were successfully weaned off NCPAP at the first attempt (P40.05). It took 1.3 (1 to 1.75) (median (IQR)) attempts and 7 (7 to 7) days to wean NCPAP off in the sprinting group vs 1.3 (1 to 1.75) attempts and 7 (7 to 10) days in the non-sprinting group (P40.05). Additionally, no differences in the secondary outcomes of bronchopulmonary dysplasia, severe retinopathy of prematurity (⩾ stage 3), periventricular leukomalacia and length of stay were noted between the two groups. CONCLUSION: Weaning NCPAP via sprinting or non-sprinting protocol is comparable, not only for successful weaning but also for the occurrence of common neonatal morbidities that impact the long-term outcome in premature infants (ClinicalTrials.gov number, NCT02819050). (2018) 
INTRODUCTION

Many studies
have demonstrated the benefits of nasal continuous positive airway pressure (NCPAP) in managing infants with respiratory distress and apnea. A growing body of observational studies, [4] [5] [6] [7] [8] clinical trials 1,9-11 and reviews [12] [13] [14] [15] suggest a role for the use of early CPAP as a means to decrease the need for mechanical ventilation without increasing morbidity. However, the optimal method of weaning off NCPAP is not established. Premature discontinuation of CPAP carries the risk of atelectasis and development of apneas and bradycardias, whereas unnecessary continuation exposes the infant to the potential side effectsgastric distension, nasal trauma, agitation and long-term consequences of alveolar over distension.
In a meta-analysis on CPAP weaning methods, Jardine et al. concluded that a successful wean tended to occur at 32 to 33 weeks corrected gestational age (CGA), at 1600 g body weight, and the commonly used methods for weaning included sudden stoppage, a gradual pressure wean and a gradual graded time off wean. 17 This study was designed to test the hypothesis that gradually increasing spontaneous breathing time off NCPAP, that is, sprinting (SP), increases successful weaning off NCPAP in infants born at o31 weeks GA.
METHODS
This prospective, two-center, randomized controlled trial was performed at Children's Hospital of Orange County and Harbor-UCLA Medical Center NICUs from January 2014 to January 2016. We compared a strategy of weaning NCPAP via SP vs non-sprinting (NSP) approach with the primary outcome assessed after 7 days on protocol and the secondary outcomes assessed prior to discharge, transfer or death. This study was approved by the Institutional Review Board at both hospitals. Informed consent was attained from at least one parent of each infant studied. Both institutions utilized bubble CPAP during the study period.
Infants included were born at 23 0/7-30 6/7 weeks gestation. On meeting the below outlined eligibility criteria, infants were randomized to wean via SP (see 'sprinting off' protocol) vs an NSP approach (see 'Weaning pressure down' protocol) in blocks of four at the each participating center. Duration of wean for each group was 72 h. Randomization list was created online via electronic randomization plan generator at the website www. randomization.com. Babies were randomly assigned, unmasked, to a group as they enrolled.
Eligibility criteria
To be enrolled in the study, infants had to be born between 23 0/7 and 30 6/7 weeks GA, on NCPAP for at least 24 h, meet the criteria defined in the 'Stability criteria' section and they had to be stable on ⩽0.3 FiO 2 for at least 24 h. Initiation of study protocol, that is, weaning from NCPAP, was started when infant met all of the following additional criteria for at least 24 h:
• At least 26 0/7 weeks CGA.
• NCPAP of 5 to 6 cm of H 2 O.
• Loaded with caffeine (caffeine citrate 20 mg kg − 1 ) or already on maintenance (caffeine citrate 10 mg kg
• Stable respiratory system assessment (respiratory rate of o70 per min, no significant chest retractions and baseline oxygen saturation 486%) and otherwise deemed clinically stable to wean of NCPAP.
• If post-surgery, infant must be at least 2 weeks postoperative and off antibiotics with no concern for repeat surgery.
• A documented hemoglobin level of ⩾ 8 g dl − 1 within 7 days of the initiation of the study.
Exclusion criteria
Infants were excluded if there was evidence of a hemodynamically or clinically significant patent ductus arteriosus diagnosed either clinically (with worsening respiratory status or pulmonary edema on chest X-ray) and/or echocardiographically; any significant congenital abnormality (abnormalities affecting a major organ system, airway or musculoskeletal system); suspected or proven sepsis (positive blood culture); or grade IV intraventricular hemorrhage.
Stability criteria
The infant met stability criteria if it required a flow of ⩽ 2 l via nasal cannula (NC, delivering heated and humidified flow) and FiO 2 of ⩽ 0.30 to keep SaO 2 levels above 86% without any documented apnea or bradycardia 420 s duration, and have a respiratory rate of o 70 for more than 24 h without significant chest retractions.
Failure criteria
The infant was deemed to have failed the intervention if infant developed increased work of breathing (intercostal recession and accessory muscle use) with respiratory rate 470 for over 1 h continuously and FiO 2 of 40.30 and/or 42 l via NC to keep SaO 2 levels over 86%, or apnea or bradycardia requiring resuscitation, ranging from bag and mask ventilation to intubation.
Sprinting protocol
Infants randomized to the SP group were slowly weaned off NCPAP per the following protocol:
• 3 h off to not42 liters NC every 12 h for first 24 h. If met stability criteria then, • 6 h off to not42 liters NC every 12 h for next 24 h. If met stability criteria then, • 9 h off to not42 liters NC every 12 h for next 24 h. If met stability criteria then, • Placed on NCPAP +5 for 24 h for re-recruitment. If met stability criteria, then • Switched to room air (no flow) or no42 liter flow via NC, that is, the providers were given the discretion of being able to wean off NCPAP by switching to 0.5 l NC and titrating as needed to keep FiO 2 to less than 0.3. They also had the option of placing the infant directly on room air if clinically deemed acceptable.
• Of note, whenever the infant failed wean, at any step during the weaning process, infant was placed one-step back on the SP protocol for at least 24 h before attempting the wean again.
Non-sprinting group
Infants randomized to the NSP group were turned off NCPAP per the following protocol:
• If the infant was on NCPAP of +6 cm of H 2 O
• Infant was weaned down to CPAP 5 × 96 h.
• If infant met the stability criteria, then infant was switched to room air (no flow) or no42 l flow via NC.
• If the infant was on NCPAP +5 cm of H 2 O
• The infant was continued on CPAP +5 cm of H 2 O × 96 h
• If infant met the stability criteria, then infant was switched to room air (no flow) or no42 liter flow via NC. For further weaning, the providers were given the same options as in the SP group.
In both groups, if the infant failed to meet stability criteria, patient was placed back on NCPAP for at least 24 h, and when stability criteria met again, the infant was placed back on the previously tolerated setting on the weaning protocol.
Outcomes measured
The primary outcome measured was the successful wean off NCPAP during the first trial, which was defined as a total of 7 days (4 days of weaning and 3 days of observation afterwards). Infants meeting the primary outcome criteria must have completed the 7 days without meeting any of the failure criteria. Secondary outcomes measured included the number of attempts to wean off NCPAP; number of days on the weaning protocol before successful NCPAP wean; the incidence of BPD, severe retinopathy of prematurity (⩾ stage 3), periventricular leukomalacia, length of stay and CGA at time of discharge. BPD, retinopathy of prematurity and periventricular leukomalacia were defined as per the CPQCC (California Perinatal Quality Care Collaborative) manual of definitions. 18 Statistical analysis Data were analyzed based on an intention-to-treat. We calculated that a total sample size of 80 (40 infants in each group) would provide 80% Figure 1 . The figure shows the number of subjects evaluated, randomized and enrolled in each group, along with reasons for non-enrollment.
Weaning 
RESULTS
One hundred and fifty-two infants were evaluated and 86 were enrolled (55 did not meet eligibility criteria and 11 declined). Forty patients each were randomized to the SP and NSP groups. Six patients were enrolled but not randomized (three were withdrawn due to parental request, two were withdrawn due to neonatologist discretion and one was extubated directly to NC) (see Figure 1 ).
Clinical and demographic data for infants in the two groups are shown in Table 1 . Infant birth weight, sex, GA at birth, CGA at study initiation, race, exposure to antenatal steroids and diagnosis of clinical chorioamnionitis (defined based on maternal temperature, fundal tenderness, foul smelling amniotic fluid requiring prenatal antibiotic administration), patent ductus arteriosus and anemia did not differ statistically between the two study groups. Baseline CPAP level on average at the time of initiation of study was +5 cm of H 2 O with FiO 2 o0.3, indicating comparable underlying initial disease severity of respiratory illness between the groups.
Thirty-one infants in the SP group vs 30 infants in the NSP were successfully weaned off NCPAP at first trial (P40.05). Number of attempts 1.3 (1 to 1.75) vs 1.33 (1 to 1.75) (median (IQR)) to wean off NCPAP and number of days on NCPAP protocol 7 (7 to 7) vs 7 (7 to 10) were also not statistically different between the two groups ( Table 2 ). The other secondary outcomes (BPD, retinopathy of prematurity, periventricular leukomalacia, length of stay and CGA at the time of discharge or transfer) were also not significantly different between the groups (Table 3) .
In analyzing center-specific data, at one institution (N = 19), we found a statistically significant greater first attempt success (P = 0.017); fewer attempts to wean off NCPAP (P = 0.018); and fewer days on study protocol (P = 0.05) with the NSP approach.
However, there were no statistically significant differences in other secondary outcomes between the groups. In the other center (N = 61), there was no statistically significant difference in the first attempt wean success, number of attempts to achieve successful wean, overall days on study protocol or any other secondary outcome between the groups (P40.05 for all).
DISCUSSION
In a randomized controlled trial, we compared SP and NSP approaches with wean of NCPAP in infants born between 23 0/7 and 30 6/7 weeks GA. There was no statistically significant difference in successful weaning off NCPAP during the first trial via SP vs NSP approach.
Some studies 1, 2, 9 have demonstrated NCPAP to be a valid alternative to intubation and surfactant administration, which has led to its increased use in recent years. The optimal timing and method of weaning from NCPAP is not established. In a survey of Australian and New Zealand neonatologists, 56% stated that their approach to NCPAP weaning was 'ad hoc', 16 rendering the present study highly relevant. Previous attempts to address the optimal NCPAP weaning strategy have been flawed due to significant methodological issues including but not limited to small sample size, selection bias, variations in patient populations studied and the lack of details on the weaning protocols used in these studies.
Only a handful of previous studies [19] [20] [21] [22] have addressed methods of weaning CPAP in neonates. Randomizing infants o1500 g BW with adequate SaO 2 levels on o 0.3 FiO 2 and NCPAP to either gradual pressure reduction or increasing the duration of time off NCPAP, Singh et al. 20 concluded that weaning pressure might lead to more rapid weaning than increasing the time off NCPAP. However, there was a significant imbalance in the number of infants randomized to each study group. In another study, comparing weaning pressure vs time off NCPAP in 24 to 31 weeks GA infants, Soe 21 found that in infants over 28 weeks GA there was no difference in success between the two approaches, but in infants 24 to 27 weeks GA, pressure weaning proved to be more effective. Unfortunately, the timing to wean from NCPAP was neither standardized nor accounted for in their analysis.
Our findings are similar to those of Rastogi et al. 23 who, in comparing sudden discontinuation vs gradual pressure weaning Weaning CPAP in very premature infants N Eze et al strategy found no difference in success between these two approaches for weaning from NCPAP. That study, however, was a single center study, had a smaller sample size (56 infants) and included somewhat larger GA infants. In contrast, Todd et al.
22
demonstrated that sudden CPAP discontinuation group vs the SP group had a shorter CPAP weaning time, total duration on CPAP, need for oxygen supplementation, duration of hospitalization, along with a reduction in the incidence of BPD. Follow-up studies 24, 25 from this cohort demonstrate that utilizing the sudden wean off method reduces CPAP time, CGA to cease CPAP, patent ductus arteriosus and BPD, without adversely affecting weight gain, and time to reach full feeds in premature babies o30 weeks gestation. It is important to point out that no study that systematically examined the success rate of yet another popular method of weaning NCPAP, that is, a gradual reduction in FiO 2 , while maintaining CPAP at 5 cm of H 2 O, has been published. However, it is anticipated that many infants not requiring supplemental oxygen while on CPAP might require it following CPAP discontinuation.
We acknowledge that due to logistic reasons this was a nonblinded study; however, the study investigators were not involved in caring for the majority of the infants involved in this study since the clinical care was provided by a large pool of attending neonatologists. Another limitation of this study is the relative imbalance in the number of infants included at the two study sites, precluding meaningful inter-center comparisons. Furthermore, although the sample size was sufficient to conclusively examine the primary outcome of this study, it was not large enough to further analyze the data based on GA substratification.
CONCLUSION
There is no statistically significant difference in successfully weaning NCPAP off in o 31 weeks GA infants between the SP vs NSP approach. Secondary outcomes such as the number of attempts and total days required for successful weaning, BPD, retinopathy of prematurity, periventricular leukomalacia and length of stay are also similar between the two groups, suggesting that there may be a role for implementing either SP or NSP method of weaning from NCPAP in a NICU and then optimizing the implemented weaning method in that unit. 
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